Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
ATRC

ATRC - AtriCure Inc Stock Price, Fair Value and News

$37.73-0.68 (-1.77%)
Market Closed

62/100

ATRC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

62/100

ATRC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$44.81

Target 3M

$40.44

Target 6M

$41.84

ATRC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ATRC Price Action

Last 7 days

-3.9%

Last 30 days

-6.7%

Last 90 days

10.7%

Trailing 12 Months

-10.4%

ATRC RSI Chart

ATRC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ATRC Valuation

Market Cap

1.9B

Price/Earnings (Trailing)

-65.2

Price/Sales (Trailing)

3.62

EV/EBITDA

-181.47

Price/Free Cashflow

56.84

ATRC Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$44.81

Target 3M

$40.44

Target 6M

$41.84

ATRC Fundamentals

ATRC Revenue

Revenue (TTM)

518.3M

Rev. Growth (Yr)

15.84%

Rev. Growth (Qtr)

-1.37%

ATRC Earnings

Earnings (TTM)

-28.8M

Earnings Growth (Yr)

96.6%

Earnings Growth (Qtr)

95.69%

ATRC Profitability

Operating Margin

74.87%

EBT Margin

-5.37%

Return on Equity

-6.04%

Return on Assets

-4.53%

Free Cashflow Yield

1.76%

ATRC Investor Care

Shares Dilution (1Y)

1.98%

Diluted EPS (TTM)

-0.61

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025480.1M499.9M518.3M0
2024414.6M430.0M447.6M465.3M
2023349.3M365.7M380.7M399.2M
2022289.6M302.8M315.6M330.4M
2021212.6M243.1M258.8M274.3M
2020230.1M212.0M210.1M206.5M
2019208.6M215.7M222.4M230.8M
2018180.4M187.0M194.8M201.6M
2017160.4M166.0M169.8M174.7M
2016135.8M142.9M149.8M155.1M
2015112.5M118.6M123.3M129.8M
201487.3M93.4M99.9M107.5M
201372.2M74.4M78.4M81.9M
201266.2M67.7M68.6M70.2M
201160.7M63.3M64.0M64.4M
201000059.0M
Get all data in R, Python etc through our Historical Stock Data APIs

About AtriCure Inc

ATRC
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
 CEO
 WEBSITEatricure.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES1050

AtriCure Inc Frequently Asked Questions

ATRC is the stock ticker symbol of AtriCure Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of AtriCure Inc is 1.88 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check ATRC's fair value in chart for subscribers.

The fair value guage provides a quick view whether ATRC is over valued or under valued. Whether AtriCure Inc is cheap or expensive depends on the assumptions which impact AtriCure Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ATRC.

As of Wed Jan 28 2026, ATRC's PE ratio (Price to Earnings) is -65.2 and Price to Sales (PS) ratio is 3.62. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ATRC PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, AtriCure Inc has provided 0.08 (multiply by 100 for percentage) rate of return.